WindRose Health Investors, LLC (WindRose), the New York-based health care private equity firm, has completed the recapitalization of Terrapin Pharmacy LLC (Terrapin), a leading specialized pharmacy offering high-touch, value-added distribution and medication adherence services and technology. Terrapin Pharmacy primarily serves consumers with severe and persistent mental illness (SPMI), intellectual and developmental disabilities (IDD), and addiction. Terms of the transaction were not disclosed.
Terrapin Pharmacy is a closed-door specialized pharmacy based in Annapolis, Maryland that serves over 4,800 consumers through relationships with community-based behavioral health and long-term care facilities across Maryland, Pennsylvania, New Jersey, Virginia, and the District of Columbia. With WindRose’s investment, Terrapin will be able to expand into new markets across the United States and increase its market share within existing markets.
WindRose partnered with Terrapin’s executive team to recapitalize the business and provide additional capital to support future growth. William Blair & Company LLC acted as financial advisor to Terrapin. Latham & Watkins LLP acted as legal advisor to WindRose, and McDermott Will & Emery LLP acted as legal advisor to Terrapin.
WindRose makes equity investments in companies that operate within the services sectors of the health care industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. WindRose is based in New York City and invests in companies throughout the United States.
This was reported by Headspace Health on January 12, 2021.
Contact information: Stephanie Jarvis, Communications, Windrose Recovery, 13850 West Capitol Drive Brookfield, Wisconsin 53005; 414-409-5300; Email: stephanie@windroserecovery.com; Website: https://windroserecovery.com/
Contact information: Terrapin Pharmacy, 601 Chinquapin Round Road, Annapolis, Maryland 21401; 443- 837-0200; Website: https://www.terrapinpharmacy.com/
